Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Top Cited Papers
- 10 February 2004
- journal article
- guideline
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (5) , 672-693
- https://doi.org/10.1161/01.cir.0000114834.85476.81
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- American College of Cardiology/American Heart Association Clinical Practice Guidelines: Part ICirculation, 2003
- Effect of Estrogen Plus Progestin on Stroke in Postmenopausal WomenJAMA, 2003
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- Task Force #1—magnitude of the prevention problem: opportunities and challengesJournal of the American College of Cardiology, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Gender Representation in TrialsControlled Clinical Trials, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998